FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2109635110> ?p ?o ?g. }

• W2109635110 abstract "Abstract Background The purpose of this study was to determine the effects of the pre-workout supplement Assault™ (MusclePharm, Denver, CO, USA) on upper and lower body muscular endurance, aerobic and anaerobic capacity, and choice reaction time in recreationally-trained males. Subjective feelings of energy, fatigue, alertness, and focus were measured to examine associations between psychological factors and human performance. Methods Twelve recreationally-trained males participated in a 3-week investigation (mean +/- SD, age: 28 +/- 5 y, height: 178 +/- 9 cm, weight: 79.2 +/- 15.7 kg, VO 2max : 45.7 +/- 7.6 ml/kg/min). Subjects reported to the human performance laboratory on three separate occasions. All participants completed a baseline/familiarization day of testing that included a maximal graded exercise test for the determination of aerobic capacity (VO 2max ), one-rep maximum (1-RM) for bench and leg press to determine 75% of 1-RM, choice reaction tests, and intermittent critical velocity familiarization. Choice reaction tests included the following: single-step audio and visual, one-tower stationary protocol, two-tower lateral protocol, three-tower multi-directional protocol, and three-tower multi-directional protocol with martial arts sticks. Subjects were randomly assigned to ingest either the supplement (SUP) or the placebo (PL) during Visit 2. Subjects were provided with the cross-over treatment on the last testing visit. Testing occurred 20 min following ingestion of both treatments. Results Significant ( p < 0.05) main effects for the SUP were observed for leg press (SUP: 13 ± 6 reps, PL: 11 ± 3 reps), perceived energy (SUP: 3.4 ± 0.9, PL: 3.1 ± 0.8), alertness (SUP: 4.0 ± 0.7, PL: 3.5 ± 0.8), focus (SUP: 4.1 ± 0.6, PL: 3.5 ± 0.8), choice reaction audio single-step (SUP: 0.92 ± 0.10 s, PL: 0.97 ± 0.11 s), choice reaction multi-direction 15 s (SUP: 1.07 ± 0.12 s, PL: 1.13 ± 0.14 s), and multi-direction for 30 s (SUP: 1.10 ± 0.11 s, PL: 1.14 ± 0.13 s). Conclusions Ingesting the SUP before exercise significantly improved agility choice reaction performance and lower body muscular endurance, while increasing perceived energy and reducing subjective fatigue. These findings suggest that the SUP may delay fatigue during strenuous exercise." @default.
• W2109635110 created "2016-06-24" @default.
• W2109635110 creator A5004535631 @default.
• W2109635110 creator A5007628096 @default.
• W2109635110 creator A5019542376 @default.
• W2109635110 creator A5019955347 @default.
• W2109635110 creator A5046959071 @default.
• W2109635110 creator A5050844876 @default.
• W2109635110 creator A5066136782 @default.
• W2109635110 creator A5082474433 @default.
• W2109635110 date "2012-03-30" @default.
• W2109635110 modified "2023-10-17" @default.
• W2109635110 title "Ingesting a pre-workout supplement containing caffeine, B-vitamins, amino acids, creatine, and beta-alanine before exercise delays fatigue while improving reaction time and muscular endurance" @default.
• W2109635110 cites W133690388 @default.
• W2109635110 cites W1963666732 @default.
• W2109635110 cites W1964869661 @default.
• W2109635110 cites W1970742954 @default.
• W2109635110 cites W2011032776 @default.
• W2109635110 cites W2019880399 @default.
• W2109635110 cites W2027189552 @default.
• W2109635110 cites W2041824571 @default.
• W2109635110 cites W2042437279 @default.
• W2109635110 cites W2078432314 @default.
• W2109635110 cites W2093077305 @default.
• W2109635110 cites W2098024411 @default.
• W2109635110 cites W2112651460 @default.
• W2109635110 cites W2116294748 @default.
• W2109635110 cites W2117597891 @default.
• W2109635110 cites W2130957616 @default.
• W2109635110 cites W2138215600 @default.
• W2109635110 cites W2140306649 @default.
• W2109635110 cites W2162128807 @default.
• W2109635110 doi "https://doi.org/10.1186/1743-7075-9-28" @default.
• W2109635110 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3361498" @default.
• W2109635110 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22463603" @default.
• W2109635110 hasPublicationYear "2012" @default.
• W2109635110 type Work @default.
• W2109635110 sameAs 2109635110 @default.
• W2109635110 citedByCount "67" @default.
• W2109635110 countsByYear W21096351102012 @default.
• W2109635110 countsByYear W21096351102013 @default.
• W2109635110 countsByYear W21096351102014 @default.
• W2109635110 countsByYear W21096351102015 @default.
• W2109635110 countsByYear W21096351102016 @default.
• W2109635110 countsByYear W21096351102017 @default.
• W2109635110 countsByYear W21096351102018 @default.
• W2109635110 countsByYear W21096351102019 @default.
• W2109635110 countsByYear W21096351102020 @default.
• W2109635110 countsByYear W21096351102021 @default.
• W2109635110 countsByYear W21096351102022 @default.
• W2109635110 countsByYear W21096351102023 @default.
• W2109635110 crossrefType "journal-article" @default.
• W2109635110 hasAuthorship W2109635110A5004535631 @default.
• W2109635110 hasAuthorship W2109635110A5007628096 @default.
• W2109635110 hasAuthorship W2109635110A5019542376 @default.
• W2109635110 hasAuthorship W2109635110A5019955347 @default.
• W2109635110 hasAuthorship W2109635110A5046959071 @default.
• W2109635110 hasAuthorship W2109635110A5050844876 @default.
• W2109635110 hasAuthorship W2109635110A5066136782 @default.
• W2109635110 hasAuthorship W2109635110A5082474433 @default.
• W2109635110 hasBestOaLocation W21096351101 @default.
• W2109635110 hasConcept C103038586 @default.
• W2109635110 hasConcept C126322002 @default.
• W2109635110 hasConcept C140793950 @default.
• W2109635110 hasConcept C141832487 @default.
• W2109635110 hasConcept C171687745 @default.
• W2109635110 hasConcept C1862650 @default.
• W2109635110 hasConcept C196310339 @default.
• W2109635110 hasConcept C2777861855 @default.
• W2109635110 hasConcept C2777953023 @default.
• W2109635110 hasConcept C2779897013 @default.
• W2109635110 hasConcept C2988918651 @default.
• W2109635110 hasConcept C2992361435 @default.
• W2109635110 hasConcept C42407357 @default.
• W2109635110 hasConcept C5140985 @default.
• W2109635110 hasConcept C71924100 @default.
• W2109635110 hasConcept C84393581 @default.
• W2109635110 hasConcept C86803240 @default.
• W2109635110 hasConceptScore W2109635110C103038586 @default.
• W2109635110 hasConceptScore W2109635110C126322002 @default.
• W2109635110 hasConceptScore W2109635110C140793950 @default.
• W2109635110 hasConceptScore W2109635110C141832487 @default.
• W2109635110 hasConceptScore W2109635110C171687745 @default.
• W2109635110 hasConceptScore W2109635110C1862650 @default.
• W2109635110 hasConceptScore W2109635110C196310339 @default.
• W2109635110 hasConceptScore W2109635110C2777861855 @default.
• W2109635110 hasConceptScore W2109635110C2777953023 @default.
• W2109635110 hasConceptScore W2109635110C2779897013 @default.
• W2109635110 hasConceptScore W2109635110C2988918651 @default.
• W2109635110 hasConceptScore W2109635110C2992361435 @default.
• W2109635110 hasConceptScore W2109635110C42407357 @default.
• W2109635110 hasConceptScore W2109635110C5140985 @default.
• W2109635110 hasConceptScore W2109635110C71924100 @default.
• W2109635110 hasConceptScore W2109635110C84393581 @default.
• W2109635110 hasConceptScore W2109635110C86803240 @default.
• W2109635110 hasIssue "1" @default.
• W2109635110 hasLocation W21096351101 @default.
• W2109635110 hasLocation W21096351102 @default.
• W2109635110 hasLocation W21096351103 @default.
• W2109635110 hasLocation W21096351104 @default.

• next